全文获取类型
收费全文 | 744篇 |
免费 | 87篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 38篇 |
妇产科学 | 9篇 |
基础医学 | 86篇 |
口腔科学 | 48篇 |
临床医学 | 110篇 |
内科学 | 117篇 |
皮肤病学 | 20篇 |
神经病学 | 72篇 |
特种医学 | 65篇 |
外科学 | 69篇 |
综合类 | 37篇 |
一般理论 | 1篇 |
预防医学 | 72篇 |
眼科学 | 2篇 |
药学 | 53篇 |
中国医学 | 4篇 |
肿瘤学 | 31篇 |
出版年
2021年 | 14篇 |
2020年 | 7篇 |
2019年 | 8篇 |
2018年 | 13篇 |
2017年 | 10篇 |
2016年 | 11篇 |
2015年 | 15篇 |
2014年 | 14篇 |
2013年 | 28篇 |
2012年 | 37篇 |
2011年 | 34篇 |
2010年 | 36篇 |
2009年 | 23篇 |
2008年 | 32篇 |
2007年 | 28篇 |
2006年 | 26篇 |
2005年 | 21篇 |
2004年 | 15篇 |
2003年 | 9篇 |
2002年 | 13篇 |
2001年 | 9篇 |
2000年 | 15篇 |
1999年 | 11篇 |
1998年 | 28篇 |
1997年 | 21篇 |
1996年 | 26篇 |
1995年 | 14篇 |
1994年 | 17篇 |
1993年 | 12篇 |
1992年 | 8篇 |
1991年 | 14篇 |
1990年 | 13篇 |
1989年 | 24篇 |
1988年 | 18篇 |
1987年 | 26篇 |
1986年 | 18篇 |
1985年 | 13篇 |
1984年 | 12篇 |
1983年 | 14篇 |
1982年 | 14篇 |
1981年 | 12篇 |
1980年 | 17篇 |
1979年 | 13篇 |
1978年 | 5篇 |
1977年 | 5篇 |
1976年 | 12篇 |
1975年 | 8篇 |
1973年 | 6篇 |
1972年 | 8篇 |
1971年 | 7篇 |
排序方式: 共有836条查询结果,搜索用时 15 毫秒
11.
目的:探讨皮质醇增多症的临床表现和内分泌检查等辅助检查的意义.方法:从年龄、性别、病程及实验室检查等方面,观察22例不同原因所致皮质醇增多症患者不同的临床表现和测定实验室检查指标.结果:22例中诊断库欣病(增生型)14例[63.6%,其中13例(92.9%)得到MRI检查证实],肾上腺腺瘤6例[27.3%,均得到MRI检查证实(100%)],另有肾上腺结节样增生1例(4.5%),异位ACTH综合征1例(4.5%).临床表现:按出现的频率前4位依次为,库欣病:高血压(100%)、满月脸(92.9%)、向心性肥胖(85.7%)、多血质(85.7%),肾上腺腺瘤:高血压(100%)、满月脸(100%)、向心性肥胖(100%)、多血质(83.3%).实验室检查:小剂量地塞米松不能抑制:库欣病与肾上腺腺瘤均为100%.结论:根据高血压、满月脸、向心性肥胖,小剂量地塞米松抑制试验和MRI检查可诊断绝大多数皮质醇增多症. 相似文献
12.
A. H. V. Schapira P. Barone R. A. Hauser Y. Mizuno O. Rascol M. Busse C. Debieuvre M. Fraessdorf W. Poewe for the Pramipexole ER Studies Group 《European journal of neurology》2013,20(1):50-56
Background and purpose: In chronic diseases including Parkinson’s disease (PD), complex pharmacotherapy dosing schedules are reported to reduce adherence, perhaps leading to less‐effective symptom control and, in PD, more erratic stimulation of dopamine receptors. However, blinded clinical‐trial designs preclude direct comparisons of adherence to various schedules. Methods: In two double‐blind (DB) studies of early PD and one of advanced PD, subjects received three‐times‐daily (t.i.d.) pramipexole or placebo. In open‐label (OL) extensions, subjects took extended‐release, once‐daily (q.d.) pramipexole. At 24 or 32 OL weeks, q.d. versus t.i.d. dosing preference was surveyed by questionnaire. Results: Of 590 DB‐trial completers with early PD, 511 entered the OL extension. Of 374 survey respondents, 94.4% preferred q.d. dosing (72.2% of them found it ‘very much more convenient’ and 27.8%‘more convenient’), 2.7% preferred t.i.d., and 2.9% chose ‘no difference’. Of 465 DB‐trial completers with advanced PD, 391 entered its OL extension. Of 334 survey respondents, 88.9% preferred q.d. dosing (59.9% of them found it ‘very much more convenient’ and 40.1%‘more convenient’), 5.7% preferred t.i.d., and 5.4% chose ‘no difference’. Results excluding DB‐placebo recipients were highly similar. Conclusions: In this first direct comparison of patient preference for q.d. versus t.i.d. dopamine‐agonist dosing, patients with early or advanced PD had a strong preference for q.d. rather than t.i.d. pramipexole. The high proportion of advanced‐PD patients declaring this preference indicates that it does not depend on whether a patient is taking concomitant PD medications dosed more frequently than q.d. 相似文献
13.
14.
Christopher T. Skidmore Tingting Zhan Erika Stuckert Maromi Nei Michael R. Sperling 《Epilepsia》2013,54(1):187-193
Purpose: Studies of seizure outcome in patients undergoing serial antiepileptic drug trials have all been uncontrolled, with no account made for the spontaneous changes in disease state that could confound the elucidation of drug effects. In addition, no study has ever looked at outcome following antiepileptic drug switch in seizure‐free patients, despite the fact that this is done routinely in clinical practice. We aimed to address both of these issues using a matched case‐cohort design. Methods: We followed patients taking phenytoin or carbamazepine in monotherapy for focal epilepsy who were being crossed over to a newer agent as part of studies on the metabolic effects of anticonvulsant therapy. Many had been seizure‐free but were being switched nonetheless due to side effects or concerns about long‐term adverse consequences. Each patient was matched with two controls of the same seizure status who were taking anticonvulsant monotherapy and whose drug was not switched. Seizure freedom over the ensuing 6 months was the primary end point. Key Findings: There were 43 cases and 86 matched controls. Twenty‐three patients (cases) had been seizure‐free on their old drug; 5 (21.7%) had seizure recurrence after drug switch compared to 2 (4.3%) of 46 matched controls. Twenty patients (cases) were having seizures on their old drug; 6 (30%) entered remission after drug switch, compared to 8 of 40 matched controls (20%). The two groups differed at baseline in number of anticonvulsants previously failed, which was the most important factor for prognosis. After statistical adjustment to account for this, seizure‐free patients had 6.53 times higher odds of seizure recurrence if switched to a new drug (95% confidence interval [CI] 1.02–61.19; p = 0.06). Non–seizure‐free patients had 1.66 times higher odds of remission if they remained on the same drug compared to switching, although this was not significant (95% CI 0.36–8.42; p = 0.532). Neither dose changes, nor drug mechanism, nor duration of seizure freedom had any bearing upon the results. Significance: Although the large majority of seizure‐free patients remain so when switched to another agent, about one sixth have a recurrence attributable to the change. Conversely, our study design provides the first evidence to suggest that most improvements in drug‐resistant patients are likely due to spontaneous remissions, not new drug introductions. These findings have conflicting implications for two competing models of comparative antiepileptic drug efficacy, which will require further study to elaborate. 相似文献
15.
Sana M. N. Abu-Dahab Elizabeth R. Skidmore Margo B. Holm Joan C. Rogers Nancy J. Minshew 《Journal of autism and developmental disorders》2013,43(10):2241-2248
We examined motor and tactile-perceptual skills in individuals with high-functioning autism (IHFA) and matched typically developing individuals (TDI) ages 5–21 years. Grip strength, motor speed and coordination were impaired in IHFA compared to matched TDI, and the differences between groups varied with age. Although tactile-perceptual skills of IHFA were impaired compared to TDI on several measures, impairments were significant only for stereognosis. Motor and tactile-perceptual skills should be assessed in children with IHFA and intervention should begin early because these skills are essential to school performance. Impairments in coordination and stereognosis suggest a broad though selective under-development of the circuitry for higher order abilities regardless of domain that is important in the search for the underlying disturbances in neurological development. 相似文献
16.
Comparison of the subacute toxicity and efficacy of 3-hydroxypyridin-4- one iron chelators in overloaded and nonoverloaded mice 总被引:3,自引:1,他引:3
Five orally effective iron chelators of the 3-hydroxypyridin-4-one series have been administered intraperitoneally to iron-overloaded and nonoverloaded male mice at a dose of 200 mg/kg/24 h for a total of 60 days to investigate the effect on iron loading and toxicity. There was a significant reduction in hepatic iron at the end of the study in the iron-overloaded mice with all compounds studied using chemical iron quantitation (P less than .001) and with Perls' stain (P less than .01). Liver iron removal with the hydroxypyridinones ranged from 37% with CP20 to 63% with CP51, compared with 46% removal for desferrioxamine (DFO). There was no significant reduction in splenic or cardiac iron with any chelator. There were no deaths in iron-overloaded animals receiving any of the hydroxypyridin-4-ones, but significantly more deaths in the nonoverloaded groups as a whole (P less than .03). No weight loss was observed with any chelator. Significant reductions in hemoglobin and white cell count were observed with CP20(L1). No histologic abnormalities of kidney, spleen, bone marrow, or stifle joints were observed. Intracytoplasmic inclusion bodies were observed in the centrilobular hepatocytes of animals administered each of the hydroxypyridin-4-ones, while the DFO-treated and control groups showed no such changes. 相似文献
17.
Aaron A Phillips Darren ER Warburton Philip N Ainslie Andrei V Krassioukov 《Journal of cerebral blood flow and metabolism》2014,34(5):794-801
Individuals with high-level spinal cord injury (SCI) experience low blood pressure (BP) and cognitive impairments. Such dysfunction may be mediated in part by impaired neurovascular coupling (NVC) (i.e., cerebral blood flow responses to neurologic demand). Ten individuals with SCI >T6 spinal segment, and 10 age- and sex-matched controls were assessed for beat-by-beat BP, as well as middle and posterior cerebral artery blood flow velocity (MCAv, PCAv) in response to a NVC test. Tests were repeated in SCI after 10 mg midodrine (alpha1-agonist). Verbal fluency was measured before and after midodrine in SCI, and in the control group as an index of cognitive function. At rest, mean BP was lower in SCI (70±10 versus 92±14 mm Hg; P<0.05); however, PCAv conductance was higher (0.56±0.13 versus 0.39±0.15 cm/second/mm Hg; P<0.05). Controls exhibited a 20% increase in PCAv during cognition; however, the response in SCI was completely absent (P<0.01). When BP was increased with midodrine, NVC was improved 70% in SCI, which was reflected by a 13% improved cognitive function (P<0.05). Improvements in BP were related to improved cognitive function in those with SCI (r2=0.52; P<0.05). Impaired NVC, secondary to low BP, may partially mediate reduced cognitive function in individuals with high-level SCI. 相似文献
18.
Mousavinejad M. Skidmore S. Barone F. G. Tyers P. Pisupati V. Poptani H. Plagge A. Barker R. A. Murray P. Taylor A. Hill C. J. 《Molecular imaging and biology》2020,22(5):1244-1254
Molecular Imaging and Biology - Human pluripotent stem cell (hPSC)-derived dopaminergic neuron progenitor cells (DAPCs) are a potential therapy for Parkinson’s disease (PD). However, their... 相似文献
19.
Geographic, seasonal, and precipitation chemistry influence on the abundance and activity of biological ice nucleators in rain and snow 总被引:1,自引:0,他引:1
下载免费PDF全文
![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Brent C. Christner Rongman Cai Cindy E. Morris Kevin S. McCarter Christine M. Foreman Mark L. Skidmore Scott N. Montross David C. Sands 《Proceedings of the National Academy of Sciences of the United States of America》2008,105(48):18854-18859
Biological ice nucleators (IN) function as catalysts for freezing at relatively warm temperatures (warmer than −10 °C). We examined the concentration (per volume of liquid) and nature of IN in precipitation collected from Montana and Louisiana, the Alps and Pyrenees (France), Ross Island (Antarctica), and Yukon (Canada). The temperature of detectable ice-nucleating activity for more than half of the samples was ≥ −5 °C based on immersion freezing testing. Digestion of the samples with lysozyme (i.e., to hydrolyze bacterial cell walls) led to reductions in the frequency of freezing (0–100%); heat treatment greatly reduced (95% average) or completely eliminated ice nucleation at the measured conditions in every sample. These behaviors were consistent with the activity being bacterial and/or proteinaceous in origin. Statistical analysis revealed seasonal similarities between warm-temperature ice-nucleating activities in snow samples collected over 7 months in Montana. Multiple regression was used to construct models with biogeochemical data [major ions, total organic carbon (TOC), particle, and cell concentration] that were accurate in predicting the concentration of microbial cells and biological IN in precipitation based on the concentration of TOC, Ca2+, and NH4+, or TOC, cells, Ca2+, NH4+, K+, PO43−, SO42−, Cl−, and HCO3−. Our results indicate that biological IN are ubiquitous in precipitation and that for some geographic locations the activity and concentration of these particles is related to the season and precipitation chemistry. Thus, our research suggests that biological IN are widespread in the atmosphere and may affect meteorological processes that lead to precipitation. 相似文献
20.